To the full analysis
Buyback calculator for Surgical Science Sweden
Surgical Science Sweden stock: key metrics
SUS.STSurgical Science Sweden had an operating margin of 11% and a return on invested capital (ROIC) of 1.8% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2014 | 55.8% | −7.2% | −7.4% |
| 2015 | 113.7% | 3.9% | 3.5% |
| 2016 | 112.2% | −0.4% | 6.4% |
| 2017 | 107.1% | −6.4% | −3.9% |
| 2018 | 109.5% | −6.2% | −6.9% |
| 2019 | 82.3% | 15.0% | 12.4% |
| 2020 | 84.3% | 19.1% | 14.9% |
| 2021 | 72.5% | 24.2% | 23.5% |
| 2022 | 66.2% | 20.3% | 23.4% |
| 2023 | 69.4% | 21.4% | 26.5% |
| 2024 | 67.6% | 16.3% | 14.9% |
| 2025 | 58.1% | 11.0% | 6.7% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2014 | −16.2% | −11.6% | −6.2% |
| 2015 | 8.2% | 5.4% | 2.9% |
| 2016 | 14.7% | −0.4% | 5.2% |
| 2017 | −2.6% | −6.1% | −2.3% |
| 2018 | −5.7% | −6.8% | −4.5% |
| 2019 | 3.1% | 6.6% | 2.8% |
| 2020 | 3.7% | 4.7% | 3.3% |
| 2021 | 2.4% | 4.9% | 2.2% |
| 2022 | 4.4% | 4.1% | 4.0% |
| 2023 | 5.4% | 4.4% | 5.0% |
| 2024 | 2.7% | 3.0% | 2.4% |
| 2025 | 1.6% | 1.8% | 1.4% |
Data status and sources
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = SEK 9.9729)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Apr 2026)
- Valuation signal Undervalued since 13 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.